An oncolytic system produces oxygen selectively in pancreatic tumor cells to alleviate hypoxia and improve immune activation
Introduction: Hypoxia is one of the important reasons for the poor therapeutic efficacy of current pancreatic cancer treatment, and the dense stroma of pancreatic cancer restricts the diffusion of oxygen within the tumor. Methods: A responsive oxygen-self-supplying adv-miRT-CAT-KR (adv-MCK) cascade...
Main Authors: | Yu Chen, Jialun Wang, Ying Huang, Jianzhuang Wu, Yue Wang, Aotian Chen, Qiyuan Guo, Yixuan Zhang, Shu Zhang, Lei Wang, Xiaoping Zou, Xihan Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Pharmacological Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1043661823004097 |
Similar Items
-
Attenuation of the Hypoxia Inducible Factor Pathway after Oncolytic Adenovirus Infection Coincides with Decreased Vessel Perfusion
by: Iris Yousaf, et al.
Published: (2020-04-01) -
The Present Status of Immuno-Oncolytic Viruses in the Treatment of Pancreatic Cancer
by: Scott D. Haller, et al.
Published: (2020-11-01) -
PTTG1 Enhances Oncolytic Adenovirus 5 Entry into Pancreatic Adenocarcinoma Cells by Increasing CXADR Expression
by: Lu Long, et al.
Published: (2023-05-01) -
Transcatheter arterial embolization combined with hypoxia-replicative oncolytic adenovirus perfusion enhances the therapeutic effect of hepatic carcinoma
by: Zhang H, et al.
Published: (2019-01-01) -
Identification of MYEOV-Associated Gene Network as a Potential Therapeutic Target in Pancreatic Cancer
by: Yu Chen, et al.
Published: (2022-11-01)